Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2018-06-08 2018-06-08
Drug Identification Number 02303647 02303647
Brand name MYLAN-ATENOLOL MYLAN-ATENOLOL
Common or Proper name ATENOLOL ATENOLOL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ATENOLOL ATENOLOL
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-07-03 2018-07-03
Actual discontinuation date 2018-06-07 2018-06-07
Remaining supply date 2018-07-03 2018-07-03
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments discontinued in shortage ID 10711. Last lot 3063119 -exp 30-jun-19 discontinued in shortage ID 10711. Last lot 3063119 -exp 30-jun-19
Health Canada comments